AgeChem Venture Fund

Summary

The main office of represented VC is situated in the Montru00e9al. The fund was located in North America if to be more exact in Canada.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Aerpio Pharmaceuticals, Sorbent Therapeutics, Alethia BioTherapeutics. We can highlight the next thriving fund investment areas, such as Therapeutics, Medical.

Besides them, we counted 3 critical employees of this fund in our database.

The important activity for fund was in 2011. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund. Opposing the other organizations, this AgeChem Venture Fund works on 4 percentage points more the average amount of lead investments.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the AgeChem Venture Fund, startups are often financed by Venture Investors, Sofinnova Investments, Novartis Venture Fund. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Venture Investors, Triathlon Medical Venture Partners. In the next rounds fund is usually obtained by Novartis Venture Fund, Venture Investors, Triathlon Medical Venture Partners.